These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9450527)

  • 1. Assessing genetic markers of tumour progression in the context of intratumour heterogeneity.
    Chapman JA; Wolman E; Wolman SR; Remvikos Y; Shackney S; Axelrod DE; Baisch H; Christensen IJ; White RA; Liebovitch LS; Moore DH; Waldman FM; Cornelisse CJ; Shankey TV
    Cytometry; 1998 Jan; 31(1):67-73. PubMed ID: 9450527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The challenge of intratumour heterogeneity in precision medicine.
    Seoane J; De Mattos-Arruda L
    J Intern Med; 2014 Jul; 276(1):41-51. PubMed ID: 24661605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome.
    Caswell DR; Swanton C
    BMC Med; 2017 Jul; 15(1):133. PubMed ID: 28716075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour heterogeneity: principles and practical consequences.
    Stanta G; Jahn SW; Bonin S; Hoefler G
    Virchows Arch; 2016 Oct; 469(4):371-84. PubMed ID: 27412632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis.
    Tellez-Gabriel M; Ory B; Lamoureux F; Heymann MF; Heymann D
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour heterogeneity and the evolution of polyclonal drug resistance.
    Burrell RA; Swanton C
    Mol Oncol; 2014 Sep; 8(6):1095-111. PubMed ID: 25087573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour heterogeneity and immune-modulation.
    Jamal-Hanjani M; Thanopoulou E; Peggs KS; Quezada SA; Swanton C
    Curr Opin Pharmacol; 2013 Aug; 13(4):497-503. PubMed ID: 23664091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited impact of intratumour heterogeneity on molecular risk assignment in endometrial cancer.
    van Esterik M; Van Gool IC; de Kroon CD; Nout RA; Creutzberg CL; Smit VTHBM; Bosse T; Stelloo E
    Oncotarget; 2017 Apr; 8(15):25542-25551. PubMed ID: 28424422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The causes and consequences of genetic heterogeneity in cancer evolution.
    Burrell RA; McGranahan N; Bartek J; Swanton C
    Nature; 2013 Sep; 501(7467):338-45. PubMed ID: 24048066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General morphological and biological features of neoplasms: integration of molecular findings.
    Diaz-Cano SJ
    Histopathology; 2008 Jul; 53(1):1-19. PubMed ID: 18282144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating intratumour heterogeneity by single-cell sequencing.
    Ren SC; Qu M; Sun YH
    Asian J Androl; 2013 Nov; 15(6):729-34. PubMed ID: 24141534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity in Gastric Cancer: From Pure Morphology to Molecular Classifications.
    Gullo I; Carneiro F; Oliveira C; Almeida GM
    Pathobiology; 2018; 85(1-2):50-63. PubMed ID: 28618420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer intratumour heterogeneity: current status and clinical implications.
    Joseph C; Papadaki A; Althobiti M; Alsaleem M; Aleskandarany MA; Rakha EA
    Histopathology; 2018 Nov; 73(5):717-731. PubMed ID: 29722058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic insights into the morass of metastatic heterogeneity.
    Hunter KW; Amin R; Deasy S; Ha NH; Wakefield L
    Nat Rev Cancer; 2018 Apr; 18(4):211-223. PubMed ID: 29422598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity.
    Zhong Q; Rüschoff JH; Guo T; Gabrani M; Schüffler PJ; Rechsteiner M; Liu Y; Fuchs TJ; Rupp NJ; Fankhauser C; Buhmann JM; Perner S; Poyet C; Blattner M; Soldini D; Moch H; Rubin MA; Noske A; Rüschoff J; Haffner MC; Jochum W; Wild PJ
    Sci Rep; 2016 Apr; 6():24146. PubMed ID: 27052161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumour cells: insights into tumour heterogeneity.
    Hayes DF; Paoletti C
    J Intern Med; 2013 Aug; 274(2):137-43. PubMed ID: 23844916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour heterogeneity in the clinic.
    Bedard PL; Hansen AR; Ratain MJ; Siu LL
    Nature; 2013 Sep; 501(7467):355-64. PubMed ID: 24048068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-tumour heterogeneity - going beyond genetics.
    Caiado F; Silva-Santos B; Norell H
    FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary tumour genetic alterations and intra-tumoral heterogeneity are maintained in xenografts of human colon cancers showing chromosome instability.
    Guenot D; Guérin E; Aguillon-Romain S; Pencreach E; Schneider A; Neuville A; Chenard MP; Duluc I; Du Manoir S; Brigand C; Oudet P; Kedinger M; Gaub MP
    J Pathol; 2006 Apr; 208(5):643-52. PubMed ID: 16450341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
    Kim JY; Gatenby RA
    Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.